Securities Purchase Agreement | 13. Securities Purchase Agreement Senior Secured Convertible Notes and Warrants On September 7, 2016, the Company issued Senior Secured Convertible Notes (“September 2016 Notes”) in the aggregate principal amount of $4,301,075 for consideration consisting of (i) a cash payment by an institutional investor (the “Investor”) in the amount of $1,000,000 together with a secured promissory note payable by the Investor to the Company (the “Investor Note”) in the principal amount of $3,000,000 to finance a portion of the purchase price, fees and expenses for the direct or indirect acquisition of Zone. The September 2016 Notes had a maturity date of December 7, 2017. As of September 30, 2017, the Investor had made the following prepayments of the Investor Note: $1,000,000 on October 25, 2016; $1,100,000 on November 16, 2016; and $900,000 on December 2, 2016. As of January 23, 2017, the Investor had accepted a total of 887,707 shares of the Company’s common stock in full payment of the September 2016 Notes. On any principal balance owed by the Company to the Investor, a 6% interest obligation was due quarterly and calculated on a 360 day basis. For the three and nine months ended September 30, 2017, the Company had interest expense of $0 and $1,217 related to the September 2016 Notes as the final principal balance was converted in January of 2017. On December 2, 2016, the Company issued two Senior Secured Convertible Notes (the “December 2016 Notes”) to the Investor in the aggregate principal amount of $6,720,000 for consideration consisting of (i) a cash payment by the Investor in the amount of $1,100,000 and (ii) a secured promissory note payable by the Investor to the Company (the “December 2016 Investor Note”) in the principal amount of $4,900,000 to aid in the funding of Zone. prior to the entity’s ability to generate revenues. The December 2016 Notes have a maturity date of August 2, 2017 which was subsequently amended to October 8, 2017. At any time, the Investor may and, so long as certain equity conditions are met, the Company may require the Investor to convert the December 2016 Notes into shares of the Company’s common stock (a “Mandatory Conversion”). On September 19, 2017 (the “Exchange Date”) the Company and the Investor entered into an Amendment and Exchange Agreement pursuant to which the Company exercised its Mandatory Conversion right as to $890,000 of the December 2016 Notes in exchange for 445,367 shares of the Company’s common stock and the Investor prepaid $670,000 of the December 2016 Investor Note, which represented the entire unpaid principal amount of the December 2016 Investor Note. On the Exchange Date, the Company issued to the Investor a Senior Promissory Note in the principal amount of $697,000 (the “September 2017 Note”) in exchange for the remaining outstanding principal amount of the December 2016 Notes. The September 2017 Note may be converted into shares of the Company’s common stock at a price of $3.00 per share. As of September 30, 2017, the Investor had not converted any portion of the September 2017 Note into shares of the Company’s common stock. The September 2017 Note is non-interest bearing. Interest for the December 2016 Notes accrued at the rate of 6%, was due quarterly and was calculated on a 360-day basis. For the three and nine months ended September 30, 2017, the Company had $12,719 and $150,265, respectively, of interest expense pertaining to the unpaid principal amount of the December 2016 Notes. On February 8, 2017, the Company issued two Senior Secured Convertible Notes (the “February 2017 Notes”) to the Investor in the aggregate principal amount of $5,681,818 for consideration consisting of a secured promissory note payable by the Investor to the Company (the “February 2017 Investor Note”) in the principal amount of $5,000,000 to aid in the funding of Zone. prior to the entity’s ability to generate revenues. The February 2017 Notes have a maturity date of October 8, 2017. As of September 30, 2017, the Investor had made the following prepayments of the February 2017 Investor Note: $2,100,000 on August 15, 2017 and $2,900,000 on August 16, 2017. As of August 28, 2017, the Investor had accepted a total of 1,852,886 shares of the Company’s common stock in full payment of the February 2017 Notes. On any principal balance owed by the Company to the Investor, a 6% interest obligation was due quarterly and calculated on a 360 day basis. For the three and nine months ended September 30, 2017, the Company had interest expense of $42,750 and $173,963 related to the February 2017 Notes as the final principal balance was converted in August of 2017. In a letter agreement executed on August 27, 2017 (the “Letter Agreement”), in consideration for the prepayment in the amount of $2,500,000 of the February 2017 Investor Note, which the Investor subsequently made on August 28, 2017, the Investor and the Company agreed that the Investor would have the right, but not the obligation, until December 31, 2017, to effect an exchange (the “Share Exchange”) of 841,250 shares of the Company’s common stock for one or more senior secured convertible promissory notes in the form of the February Additional Note (the “New Note”), with the right to substitute the alternate conversion price of the New Note with the alternate conversion price of the Company’s Series B Senior Secured Convertible Note (the “Series B Note”) that was issued on August 16, 2017. Any New Note issued would be in the principal amount equal to the product of the prepayment amount ($2,500,000) multiplied by a fraction, the numerator of which is the number of the aggregate shares being tendered to the Company in the Share Exchange and the denominator of which is 841,250. The maturity date of any New Note will be 45 days following the issuance of the New Note, and the conversion price of the New Notes will be $4.50 or, at the election of the Investor, the Investor may convert at the Alternate Conversion Price. The Alternate Conversion Price is defined as either (A) the lower of (i) $4.50 and (ii) the greater of (I) $4.00 and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the common stock for each of the 5 consecutive trading days ending on the trading day immediately preceding the delivery of the Conversion Notice, divided by (y) 5 or (B) that price which shall be the lowest of (i) $3.00 and (ii) the greater of (I) the Floor Price then in effect and (II) 85% of the quotient of (x) the sum of the volume weighted average price of the Company’s common stock for each of the 5 consecutive trading days ending and including the date of the alternate conversion, divided by (y) 5. The Floor Price is defined as $3.00 through October 4, 2017 and $0.50 following October 4, 2017. On August 16, 2017, the Company issued three Senior Secured Convertible Notes (the “August 2017 Notes”) in the aggregate principal amount of $10,300,000 and a 5-year warrant for the purchase of 1,892,972 shares of the Company’s common stock at an exercise price of $3.25 per share (the “Investor Warrant”) to the Investor for consideration consisting of a secured promissory note payable by the Investor to the Company (the “August 2017 Investor Note”) in the principal amount of $8,800,000 and $220,000 in cash to aid in the funding of the acquisition of the MoviePass Shares. The August 2017 Notes have a maturity date of April 16, 2018 and the Investor Warrant will expire on April 16, 2022. At any time the Investor may and, so long as certain equity conditions are met, the Company may require the Investor to, convert the August 2017 Notes into shares of the Company’s common stock (a “Mandatory Conversion”). At September 30, 2017, the contracted conversion prices for the August 2017 Notes, which include an Initial Series A Note, an Additional Series A Note and the Series B Note, were $4.00 for the Initial Series A Note and the Additional Series A Note and $3.00 for the Series B Note. In the event of a Mandatory Conversion, the conversion will be made at the Mandatory Conversion Price which is defined as that price which is the lower of (i) the applicable Conversion Price as in effect on the applicable Mandatory Conversion date, and (ii) 80% of the sum of (A) the volume weighted average price of the common stock for each of the 3 trading days with the lowest volume weighted average price during the 20-consecutive trading day period ending on and including the trading day immediately prior to the applicable Mandatory Conversion date divided by (B) 3. As of September 30, 2017, the Investor had paid $1,830,000 of the August 2017 Investor Note with the balance of the principal amount payable in full to the Company on April 16, 2018. As of September 30, 2017, the unpaid principal amount of the August 2017 Notes owed to the Investor was $6,970,000 which was offset by the same principal amount owed to the Company pursuant to the August 2017 Investor Note. As of September 30, 2017 the Investor had not converted any of the August 2017 Notes into shares of the Company’s common stock nor had the Investor Warrant been exercised. On any principal balance owed by the Company to the Investor, a 6% interest obligation is due quarterly and calculated on a 360-day basis. For the three and nine months ended September 30, 2017, the Company had $67,875 and $67,875, respectively, of interest expense pertaining to the unpaid principal amount of the August 2017 Notes. The Investor Warrant contains anti-dilution provisions. These anti-dilution provisions were triggered when the Company issued the September 2017 Note in the principal amount of $697,000 to the Investor. Because the September 2017 Note has a conversion price of $3.00 per share, which is lower than the Investor Warrant per share exercise price of $3.25, the number of shares of the Company’s common stock issuable to the Investor pursuant to the Investor Warrant was increased from 1,892,972 to 2,050,720 and the per share exercise price of the Investor Warrant was decreased from $3.25 to $3.00. The Placement Agent Notes and Warrants The Company entered into an agreement with a placement agent (the “Placement Agent”) for assistance with the placement of the September 2016 Notes. The Placement Agent accepted from the Company a Senior Secured Convertible Note (the “September Placement Note”) in the aggregate amount of $80,000 in partial payment of the Placement Agent’s fee. Unless earlier converted or redeemed, the September Placement Note matures 15 months from the date of issuance. The Placement Agent Note bears interest at a rate of 6% due quarterly and calculated on a 360-day basis. For the three and nine months ended September 30, 2017, the Company had interest expense pertaining to the September Placement Note in the amount of $0 and $1,200 respectively. The Placement Agent also received a 5-year warrant (the “Placement Agent Warrant”) for the purchase of the Company’s common stock as partial payment for the Placement Agent’s services. The Placement Agent Warrant is issued in tranches in conjunction with cash payments received by the Company on the corresponding Investor Note. During 2016, warrants were earned allowing for the purchase of 48,714 shares of the Company’s common stock at exercise prices ranging from $4.54 per share to $9.36 per share. As of September 30, 2017 the Placement Agent had not purchased any shares from the exercise of the Placement Agent Warrant. The Company entered into an agreement with the Placement Agent for assistance with the placement of the December Notes. The Placement Agent accepted from the Company a 5-year warrant (the “December Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The December Placement Agent Warrant is issued in tranches in conjunction with cash payments received by the Company on the corresponding December 2016 Investor Note. As of December 31, 2016, the Placement Agent had the right to purchase, pursuant to the terms of the December Placement Agent Warrant, 22,000 shares of the Company’s common stock at an exercise price of $4.45 per share. Through the first nine months of 2017 the Company has received $4,900,000 of cash payments for the December Notes, resulting in the issuance of an additional 104,001 warrants at exercise prices of $3.00 per share, $3.47 per share, $4.00 per share and $6.13 per share. As of September 30, 2017 the Placement Agent had not purchased any shares from the exercise of the December Placement Agent Warrant. The Company entered into an agreement with the Placement Agent for assistance with the placement of the February 2017 Notes. The Placement Agent accepted from the Company a 5-year warrant (the “February Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The February Placement Agent Warrant allows the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the February 2017 Notes may be converted. Through the first nine months of 2017 the Company received $5,000,000 of cash payments for the February 2017 Notes, resulting in the issuance of an additional 133,334 warrants at an exercise price of $3.00 per share. As of September 30, 2017 the Placement Agent had not purchased any shares from the exercise of the February Placement Agent Warrant. The Company entered into an agreement with the Placement Agent for assistance with the placement of the August 2017 Notes and Investor Warrant. The Placement Agent accepted from the Company a 5-year warrant (the “August Placement Agent Warrant”) as partial payment for the Placement Agent’s services. The August Placement Agent Warrant allows the purchase of up to 8% of the number of shares of the Company’s common stock into which the unrestricted principal of the Additional Series A Note and the Series B Note in the combined principal amount of $9,050,000 becomes convertible at an exercise price equal to the greater of the exercise price of the August 2017 Notes and the consolidated closing bid price of the Company’s common stock on the date that the Placement Agent becomes entitled to the warrant. During the period ended September 30, 2017, the Company received $2,050,000 of cash payments for the August 2017 Notes resulting in the issuance of 42,467 warrants at exercise prices of $3.00 and $6.13 per share. As of September 30, 2017 the Placement Agent had not purchased any shares from the exercise of the August Placement Agent Warrants. Note Activity: Senior Secured Convertible Notes consist of the following: September 30, December 31, September 2016 notes $ - $ 20,480 September Placement Agent Note - 902 December 2016 notes - 10,043 February 2017 notes - - August 2017 notes 335,215 - February 2017 notes 46,029 - Balance at period end $ 381,244 $ 31,425 Under ASC 210-20-45-1, management offset the Notes by the Investor Notes yet to be funded. The carrying value of the Senior Secured Convertible Notes is comprised of the following: September 30, December 31, September 2016 notes $ - $ 332,000 September Placement Agent Note - 80,000 December 2016 notes - 1,820,000 February 2017 notes - - August 2017 Notes 3,330,000 September 2017 Notes 697,000 Unamortized discounts (3,645,756 ) (2,200,575 ) Carrying value $ 381,244 $ 31,425 During the three and nine months ended September 30, 2017, the Investor converted a total of $6,066,818 and $12,723,818 in principal and $55,569 and $106,178 in interest into 2,185,663 and 3,862,623 shares of the Company’s common stock. On October 6, 2017 the Company received a prepayment of the August 2017 Investor Note in the amount of $6,970,000. |
Securities Purchase Agreement | 4. Securities Purchase Agreement On August 15, 2017 the Company and MoviePass Inc., a privately held Delaware corporation (“MoviePass”), entered into a securities purchase agreement (the “MoviePass SPA”), pursuant to which the Company agreed to purchase shares of common stock of MoviePass equal to fifty one percent of the then outstanding shares of MoviePass’ common stock (the “MoviePass Shares”) for an aggregate purchase price of up to $27,000,000 which is subject to the satisfaction or waiver of certain conditions set forth in the MoviePass SPA. MoviePass is a subscription-based service that allows moviegoers to see a number of movies in movie theaters for a monthly fee. At the closing of the MoviePass transaction, in exchange for the MoviePass Shares, the Company will issue to MoviePass (i) 3,333,334 unregistered shares of HMNY’s common stock for a total agreed upon value of approximately $10,000,000; and (ii) a promissory note in the principal amount of $10,000,000. Of the Company’s common shares being offered, 666,667 shares shall be subject to forfeiture by MoviePass if MoviePass fails to achieve either of the following two milestones within the specified time frame: (A) within one year after the closing, subscribers to MoviePass’ MoviePass product shall have exceeded on at least one day 100,000 subscribers, and (B) MoviePass’ common stock shall have been listed on The Nasdaq Stock Market (“Nasdaq”) or New York Stock Exchange by January 31, 2018. As of September 30, 2017, the MoviePass transaction had not been completed. On October 6, 2017, the Company and MoviePass amended the MoviePass SPA in connection with an additional loan made by the Company to MoviePass in the amount of $6,500,000. Of the loan amount, $1,500,000 will be allocated, upon the completion of the transaction, to the purchase of additional shares of MoviePass common stock, thereby increasing the purchase price from $27,000,000 to $28,500,000. On October 11, 2017, the Company and MoviePass entered into an investment option agreement (the “Option Agreement”), pursuant to which the Company was granted an option to purchase additional shares of MoviePass common stock in an amount up to $20 million based on a pre-money valuation of MoviePass of $210,000,000 (the “MoviePass Option”) amounting to an additional investment of up to 8.7% of the currently outstanding shares of MoviePass common stock (as defined in the MoviePass Option Agreement), giving effect to the closing of the transaction. The MoviePass Option may be exercised by the Company until 5:00 p.m. Eastern Time on the thirtieth day after the Company receives MoviePass’ audited financial statements for the years ended December 31, 2016 and 2015 and the reviewed unaudited interim financial statements for the periods ended September 30, 2017 and 2016. |